Enterprise Value
-54.62M
Cash
124.7M
Avg Qtr Burn
-18.76M
Short % of Float
7.75%
Insider Ownership
3.31%
Institutional Own.
66.00%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AVR-RD-05 Details Mucopolysaccharidoses, Mucopolysaccharidosis type II, Rare diseases, Rare genetic disease, Genetic disorder | Failed Discontinued | |
AVR-RD-04 Details Cystinosis | Failed Discontinued | |
AVR-RD-02 Details Gaucher disease | Failed Discontinued | |
AVR-RD-01 Details Genetic disorder, Fabry disease | Failed Discontinued |